Eli Lilly Stock News

Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medi

Targeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule.

Walmart is a retail beast with an appetite for growth, which makes it likely this company won't just stand pat in the future. Apple's business showed signs of slowing last quarter, but artificial inte

Eli Lilly's once-weekly insulin product just aced phase 3 studies. The company will battle its eternal rival, Novo Nordisk, in this market.

Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.

More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows, raising questions about how societal views of women's weight may influence use of these medica

Stock market investing offers wealth-building opportunities for those with a long-term investing time horizon. However, high rewards entail high risks, especially for those seeking quick gains.

Geoff Meacham, BofA Securities managing director, joins 'Closing Bell Overtime' to talk Eli Lilly closing at a record high and what's driving it higher.

Eli Lilly (LLY) is higher after Chinese regulators approve diabetes drug in China. Diane King Hall discusses this as Eli Lilly's Phase 3 study of Crohn's disease treatment achieves “meaningful impro

Shares of Eli Lilly (LLY) were on track to close at an all-time high Tuesday as a study showed the pharmaceutical giant's current drug for ulcerative colitis also was successful in treating Crohn's di

The rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.

Eli Lilly stock breaks out of a double-bottom base after the pharmaceutical company releases positive data about its Crohn's Disease treatment. New to trading?

Eli Lilly & Co. LLY shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-stage Crohn's disease trial and struck a deal to develop new cancer-targeting me

Eli Lilly's weight loss drugs are driving growth at the pharma company, generating billions of dollars in revenue. This could continue, considering the strong demand for the products.

BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, announced today a licensing agreeme